A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

NCT07239947 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: BBT001
DRUG: Placebo

Sponsor

Bambusa Therapeutics